{"date":"2026-02-22","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4116-2026-02-22-2115-151vtax","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-02-22","time":"21:15:14","subject":"民國114年第四季財務報告董事會預計召開日期為民國115年03月02日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-02-22 21:15，「民國114年第四季財務報告董事會預計召開日期為民國115年03月02日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-02-22-1026-1a0vqc3","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-02-22","time":"10:26:42","subject":"公告本公司Bonvadis外用乳膏，取得哥倫比亞食品藥物管理局(INVIMA)核准完全傷口適應症之醫材上市許可","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-02-22 10:26，「公告本公司Bonvadis外用乳膏，取得哥倫比亞食品藥物管理局(INVIMA)核准完全傷口適應症之醫材上市許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}